Claire Mazumdar
Chief Executive Officer, Bicara Therapeutics Inc.
Companies
- Relay TherapeuticsBoard member Jun 11, 2025 to now1
- Bicara Therapeutics Inc.Board member Sep 12, 2024 to now2
- Bicara Therapeutics Inc.Chief executive officer Sep 12, 2024 to Sep 10, 20262
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Bicara Therapeutics Inc. BCAX362,152 shares3$6.2M at $17.14Aug 10, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- Aug 10, 2026Sold 10,000 shares at $27.98 of Bicara Therapeutics Inc.3
- Aug 10, 2026Exercised options 10,000 shares at $3.79 of Bicara Therapeutics Inc.3
- Jul 10, 2026Sold 28 shares at $29.68 of Bicara Therapeutics Inc.4
- Jul 10, 2026Sold 9,972 shares at $28.42 of Bicara Therapeutics Inc.4
- Jul 10, 2026Exercised options 10,000 shares at $3.79 of Bicara Therapeutics Inc.4
- May 18, 2026Sold 2,978 shares at $20.35 of Bicara Therapeutics Inc.5
- May 18, 2026Sold 12,022 shares at $19.96 of Bicara Therapeutics Inc.5
- May 18, 2026Exercised options 15,000 shares at $3.79 of Bicara Therapeutics Inc.5
- Apr 20, 2026Sold 15,000 shares at $23.61 of Bicara Therapeutics Inc.6
- Apr 20, 2026Exercised options 15,000 shares at $3.79 of Bicara Therapeutics Inc.6
- Apr 16, 2026Exercised options 7,080 shares at $5.45 of Bicara Therapeutics Inc.6
- Apr 16, 2026Exercised options 7,454 shares at $3.79 of Bicara Therapeutics Inc.6
- Apr 16, 2026Exercised options 8,226 shares at $4.44 of Bicara Therapeutics Inc.6
- Mar 20, 2026Sold 1,596 shares at $18.95 of Bicara Therapeutics Inc.7
- Mar 20, 2026Exercised options 1,596 shares at $3.79 of Bicara Therapeutics Inc.7
- Mar 19, 2026Sold 6,905 shares at $18.78 of Bicara Therapeutics Inc.7
- Mar 19, 2026Exercised options 6,905 shares at $3.79 of Bicara Therapeutics Inc.7
- Mar 18, 2026Sold 6,499 shares at $18.84 of Bicara Therapeutics Inc.7
- Mar 18, 2026Exercised options 6,499 shares at $3.79 of Bicara Therapeutics Inc.7
- Mar 9, 2026Sold 36,766 shares at $19.17 of Bicara Therapeutics Inc.8
- Mar 9, 2026Exercised options 36,766 shares at $3.79 of Bicara Therapeutics Inc.8
- Mar 6, 2026Sold 3,817 shares at $18.75 of Bicara Therapeutics Inc.9
- Mar 6, 2026Exercised options 3,817 shares at $3.79 of Bicara Therapeutics Inc.9
- Mar 5, 2026Sold 1,786 shares at $18.74 of Bicara Therapeutics Inc.9
- Mar 5, 2026Exercised options 1,786 shares at $3.79 of Bicara Therapeutics Inc.9
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARRelay Therapeutics, Board member
- 2
- 3
- 4SEC EDGARForm 4 filed Jul 14, 2026
- 5SEC EDGARForm 4 filed May 20, 2026
- 6SEC EDGARForm 4 filed Apr 20, 2026
- 7SEC EDGARForm 4 filed Mar 20, 2026
- 8SEC EDGARForm 4 filed Mar 11, 2026
- 9SEC EDGARForm 4 filed Mar 6, 2026